Search Results

Displaying Results 26-27 of 27 "'PMD'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5% During the Forecast Period (2025-2034) Driven by Recent Approvals and Pipeline Advancements and Rising Awareness | DelveInsight

Nov 25, 2025, 17:31 ET Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5% During the Forecast Period (2025-2034) Driven by Recent Approvals and Pipeline Advancements and Rising Awareness | DelveInsight

Clinical studies include a Phase I trial in healthy volunteers, three trials in patients with m.3243A>G PMD (KHENERGY, KHENERGYZE, KHENEREXT), and a pediatric trial (KHENERGYC) in children with PMD.Discover more about the mitochondrial myopathies drugs market @

More news about: DelveInsight Business Research, LLP

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.